- Home
- TRVI vs WHF Comparison
TRVI vs WHF Comparison
Compare TRVI & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- WHF
- Stock Information
- Founded
- TRVI 2011
- WHF 2011
- Country
- TRVI United States
- WHF United States
- Employees
- TRVI N/A
- WHF N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- WHF Finance Companies
- Sector
- TRVI Health Care
- WHF Finance
- Exchange
- TRVI Nasdaq
- WHF Nasdaq
- Market Cap
- TRVI 211.4M
- WHF 243.6M
- IPO Year
- TRVI 2019
- WHF 2012
- Fundamental
- Price
- TRVI $4.51
- WHF $10.74
- Analyst Decision
- TRVI Strong Buy
- WHF Hold
- Analyst Count
- TRVI 8
- WHF 4
- Target Price
- TRVI $9.31
- WHF $12.25
- AVG Volume (30 Days)
- TRVI 4.0M
- WHF 94.3K
- Earning Date
- TRVI 11-06-2024
- WHF 11-07-2024
- Dividend Yield
- TRVI N/A
- WHF 14.56%
- EPS Growth
- TRVI N/A
- WHF N/A
- EPS
- TRVI N/A
- WHF 0.45
- Revenue
- TRVI N/A
- WHF $97,441,000.00
- Revenue This Year
- TRVI N/A
- WHF N/A
- Revenue Next Year
- TRVI N/A
- WHF N/A
- P/E Ratio
- TRVI N/A
- WHF $23.70
- Revenue Growth
- TRVI N/A
- WHF N/A
- 52 Week Low
- TRVI $1.26
- WHF $10.35
- 52 Week High
- TRVI $4.60
- WHF $13.44
- Technical
- Relative Strength Index (RSI)
- TRVI 75.02
- WHF 42.96
- Support Level
- TRVI $2.36
- WHF $10.48
- Resistance Level
- TRVI $4.60
- WHF $10.83
- Average True Range (ATR)
- TRVI 0.33
- WHF 0.17
- MACD
- TRVI 0.21
- WHF 0.05
- Stochastic Oscillator
- TRVI 92.46
- WHF 53.12
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate attractive risk-adjusted returns for investors, primarily by originating senior secured loans to privately held small-cap companies across a broad range of industries.